308 related articles for article (PubMed ID: 35653821)
21. Preliminary Efficacy of a Theory-Informed Intervention to Increase COVID-19 Testing Uptake Among People Who Inject Drugs in San Diego County: Findings From a Pilot Randomized Controlled Trial.
Bazzi AR; Abramovitz D; Harvey-Vera A; Stamos-Buesig T; Vera CF; Artamonova I; Logan J; Patterson TL; Strathdee SA
Ann Behav Med; 2023 May; 57(6):472-482. PubMed ID: 37029714
[TBL] [Abstract][Full Text] [Related]
22. Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response.
Wilkinson R; Hines L; Holland A; Mandal S; Phipps E
Harm Reduct J; 2020 Dec; 17(1):95. PubMed ID: 33261636
[TBL] [Abstract][Full Text] [Related]
23. Young and invisible: a qualitative study of service engagement by people who inject drugs in India.
Ganapathi L; Srikrishnan AK; Martinez C; Lucas GM; Mehta SH; Verma V; McFall AM; Mayer KH; Hassan A; Rajan S; O'Cleirigh C; Harris SK; Solomon SS
BMJ Open; 2021 Sep; 11(9):e047350. PubMed ID: 34548348
[TBL] [Abstract][Full Text] [Related]
24. The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usual.
Gilchrist G; Swan D; Shaw A; Keding A; Towers S; Craine N; Munro A; Hughes E; Parrott S; Strang J; Taylor A; Watson J
Harm Reduct J; 2017 Mar; 14(1):14. PubMed ID: 28320406
[TBL] [Abstract][Full Text] [Related]
25. The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: A qualitative study.
Dunleavy K; Hope V; Roy K; Taylor A
Int J Drug Policy; 2019 Mar; 65():65-72. PubMed ID: 30665085
[TBL] [Abstract][Full Text] [Related]
26. "Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID-19 in Hai Phong, Vietnam".
Giang HT; Duc NQ; Molès JP; Vinh VH; Nagot N; Thanh NTT; Huong DT; Oanh KTH; Khue PM; Mai LS; Trang NT; Ngoc PT; Quillet C; Feelemyer J; Vallo R; Michel L; Jarlais DD; Laureillard D; Rapoud D
Int J Drug Policy; 2022 Dec; 110():103870. PubMed ID: 36244242
[TBL] [Abstract][Full Text] [Related]
27. The health and social consequences during the initial period of the COVID-19 pandemic among current and former people who inject drugs: A rapid phone survey in Baltimore, Maryland.
Genberg BL; Astemborski J; Piggott DA; Woodson-Adu T; Kirk GD; Mehta SH
Drug Alcohol Depend; 2021 Apr; 221():108584. PubMed ID: 33607497
[TBL] [Abstract][Full Text] [Related]
28. Health service utilisation and access for people who inject drugs during COVID-19.
Efunnuga H; Higgs P; Walker S; O'Keefe D
Drug Alcohol Rev; 2022 Sep; 41(6):1304-1310. PubMed ID: 35266229
[TBL] [Abstract][Full Text] [Related]
29. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
[TBL] [Abstract][Full Text] [Related]
30. Missed opportunities for healthcare providers to discuss HIV preexposure prophylaxis with people who inject drugs.
Vincent W; McFarland W
Int J Drug Policy; 2022 Dec; 110():103873. PubMed ID: 36252292
[TBL] [Abstract][Full Text] [Related]
31. "It's Russian roulette": adulteration, adverse effects and drug use transitions during the 2010/2011 United Kingdom heroin shortage.
Harris M; Forseth K; Rhodes T
Int J Drug Policy; 2015 Jan; 26(1):51-8. PubMed ID: 25444768
[TBL] [Abstract][Full Text] [Related]
32. Impact of COVID-19 on substance use disorder treatment services in Kenya: Qualitative findings from healthcare providers.
Muller A; Akiyama MJ; Riback L; Nyakowa M; Musyoki H; Cherutich P; Kurth A
Int J Drug Policy; 2022 Jul; 105():103710. PubMed ID: 35580533
[TBL] [Abstract][Full Text] [Related]
33. Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study.
Cooper L; Rosen JG; Zhang L; Pelaez D; Olatunde PF; Owczarzak J; Park JN; Glick JL
Harm Reduct J; 2023 Jun; 20(1):71. PubMed ID: 37296423
[TBL] [Abstract][Full Text] [Related]
34. The Impact of the COVID-19 Pandemic and Associated Societal Restrictions on People Experiencing Homelessness (PEH): A Qualitative Interview Study with PEH and Service Providers in the UK.
Dawes J; May T; Fancourt D; Burton A
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497601
[TBL] [Abstract][Full Text] [Related]
35. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings.
Bolinski RS; Walters S; Salisbury-Afshar E; Ouellet LJ; Jenkins WD; Almirol E; Van Ham B; Fletcher S; Johnson C; Schneider JA; Ompad D; Pho MT
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206421
[TBL] [Abstract][Full Text] [Related]
36. Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland.
Patel EU; Grieb SM; Winiker AK; Ching J; Schluth CG; Mehta SH; Kirk GD; Genberg BL
Harm Reduct J; 2024 May; 21(1):91. PubMed ID: 38720307
[TBL] [Abstract][Full Text] [Related]
37. Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugs.
Tookes HE; Bartholomew TS; Suarez E; Ekowo E; Ginoza M; Forrest DW; Serota DP; Rodriguez A; Kolber MA; Feaster DJ; Mooss A; Boyd D; Sternberg C; Metsch LR
Drug Alcohol Depend; 2021 Dec; 229(Pt A):109124. PubMed ID: 34781096
[TBL] [Abstract][Full Text] [Related]
38. 'They already operated like it was a crisis, because it always has been a crisis': a qualitative exploration of the response of one homeless service in Scotland to the COVID-19 pandemic.
Parkes T; Carver H; Masterton W; Falzon D; Dumbrell J; Grant S; Wilson I
Harm Reduct J; 2021 Mar; 18(1):26. PubMed ID: 33658042
[TBL] [Abstract][Full Text] [Related]
39. Patient and Provider Perspectives on a Novel, Low-Threshold HIV PrEP Program for People Who Inject Drugs Experiencing Homelessness.
Bazzi AR; Shaw LC; Biello KB; Vahey S; Brody JK
J Gen Intern Med; 2023 Mar; 38(4):913-921. PubMed ID: 35614171
[TBL] [Abstract][Full Text] [Related]
40. Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks.
Vasylyeva TI; Smyrnov P; Strathdee S; Friedman SR
J Int AIDS Soc; 2020 Jul; 23(7):e25583. PubMed ID: 32697423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
